Treatment of atopic dermatitis with the xenon chloride excimer laser

@article{Balts2006TreatmentOA,
  title={Treatment of atopic dermatitis with the xenon chloride excimer laser},
  author={Eszter Balt{\'a}s and Z R Csoma and L Bodai and Ferenc Ign{\'a}cz and Attila Dobozy and Lajos V. Kem{\'e}ny},
  journal={Journal of the European Academy of Dermatology and Venereology},
  year={2006},
  volume={20}
}
Background  Narrow‐band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow‐band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow‐band ultraviolet B. 
Excimer laser vs. clobetasol propionate 0·05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot
TLDR
The 308‐nm xenon chloride excimer laser appears to be a promising treatment for the prurigo form of atopic dermatitis (AD), as it enables high radiant exposure of narrowband UVB and precise targeting of affected skin. Expand
Beyond the Booth: Excimer Laser for Cutaneous Conditions.
TLDR
The excimer laser is an alternative to standard narrowband ultraviolet B (NBUVB) phototherapy treatment in patients with limited disease and requires fewer treatment sessions, has reduced treatment duration, requires a lower cumulative UVB dose, and limits UVB exposure to lesional skin. Expand
Excimer Laser Therapy
TLDR
Excimer laser therapy is a new valuable option for treating various dermatologic conditions and the mechanism of action is similar to the UVB phototherapy; however, the cumulative dosage is lower, and the targeted area is strictly the lesional one; currently, fewer side effects are noticed. Expand
A pilot study showing pulsed‐dye laser treatment improves localized areas of chronic atopic dermatitis
TLDR
Eczematous skin changes overlying port‐wine stains have been reported to improve with pulsed‐dye laser treatment but PDL has not as yet been evaluated for the treatment of atopic dermatitis (AD; eczema). Expand
Effect of a 308‐nm excimer laser on atopic dermatitis‐like skin lesions in NC/Nga mice
TLDR
Evaluating the therapeutic effects of a 308‐nm laser on AD‐like skin lesions in NC/Nga mice found it to be a safe and effective treatment for inflammatory skin diseases. Expand
Advances in phototherapy for psoriasis and atopic dermatitis
TLDR
This review provides an update on the different forms of phototherapy used for the treatment of psoriasis and atopic dermatitis, including the immunosuppressive effect of UV light, the anti-inflammatory effect of vascular lasers and the LLLT induced photobiomodulation. Expand
Successful Treatment of Refractory Atopic Dermatitis With the Use of High-Peak Power 1064 nm Nd:YAG Laser Therapy
Atopic dermatitis is a chronic inflammatory skin disease involving the complex association of genetic, immunologic, and environmental causes. Until recently, the treatment of eczematous processes wasExpand
Excimer laser versus clobetasol propionate 0 . 05 % ointment in prurigo form of atopic dermatitis : a randomized controlled trial , a pilot Submitted
Background: Recent findings establish the 308 xenon chloride (XeCl) excimer laser (EL) to be a new option in the area of UVB phototherapy. Since the EL enables high radiant exposure of narrow-bandExpand
308nm excimer laser in dermatology.
TLDR
Although the 308-nm excimer laser appears to act as a promising treatment modality in dermatology, further large-scale studies should be undertaken in order to fully affirm its safety profile considering the potential risk, however minimal, of malignancy, it may impose. Expand
Targeted phototherapy.
  • V. Mysore
  • Medicine
  • Indian journal of dermatology, venereology and leprology
  • 2009
TLDR
Targeted phototherapy, which includes laser and nonlaser technologies, delivers light/laser in the ultraviolet spectrum, of specific wavelength, specifically targeted at the affected skin and thereby avoids many of the side effects of conventional phototherapy. Expand
...
1
2
3
4
5
...

References

SHOWING 1-9 OF 9 REFERENCES
Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial
TLDR
Narrow-band UVB is an effective adjunctive treatment for moderate to severe atopic eczema, and the treatment is well tolerated by most patients. Expand
Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B.
TLDR
The results suggest that the more effective induction of T cell apoptosis can be responsible for the greater clinical efficacy of XeCl laser compared to NB-UVB. Expand
Recent advances in phototherapy.
TLDR
Despite the documented benefits of these new treatment modalities, little data exist as of yet on potential long-term side effects, thus the indications for these therapies should be considered carefully and patients should be followed up at regular intervals. Expand
High-dose UVA1 therapy in the treatment of patients with atopic dermatitis.
TLDR
It is indicated that high-dose UVA1 irradiation may represent a novel phototherapeutic modality for the treatment of patients with an acute exacerbation of atopic dermatitis. Expand
Treatment of severe atopic dermatitis with extracorporeal photopheresis
TLDR
Preliminary results indicate that extracorporeal photopheresis may interfere with the pathomechanisms leading to atopic dermatitis and therefore should be considered as a treatment modality for severe forms of this recalcitrant disorder. Expand
Half‐side comparison study on the efficacy of 8‐methoxypsoralen bath‐PUVA versus narrow‐band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis
TLDR
The data confirm the high efficacy of bath‐PUVA and narrow‐band UVB phototherapy in the treatment of patients with chronic severe AD and appear to be equally effective when administered in equi‐erythemogenic doses. Expand
Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients.
TLDR
The calculated risk corresponded within the limits of statistical error with observed long-term risk of UVB therapy in Sweden; as far as there was a deviation, the model calculations tended to over-estimate the risk. Expand